BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8762107)

  • 1. Inhibition of purinergic transmission by prostaglandin E1 and E2 in the guinea-pig vas deferens: an electrophysiological study.
    Brock JA; Cunnane TC
    Br J Pharmacol; 1996 Jun; 118(3):776-82. PubMed ID: 8762107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An electrophysiological study of the actions of angiotensin II at the sympathetic neuroeffector junction in the guinea-pig vas deferens.
    Ziogas J; Cunnane TC
    Br J Pharmacol; 1991 May; 103(1):1196-202. PubMed ID: 1878757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha 2-adrenoceptor-mediated autoinhibition of sympathetic transmitter release in guinea-pig vas deferens studied by intracellular and focal extracellular recording of junction potentials and currents.
    Brock JA; Cunnane TC; Starke K; Wardell CF
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Jul; 342(1):45-52. PubMed ID: 1976231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contractile responses of isolated guinea-pig vas deferens to trains of electrical stimuli and influence of prostaglandin E2.
    Venkova K; Radomirov R
    Pharmacol Res Commun; 1988 Apr; 20(4):277-92. PubMed ID: 3164479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation by prostaglandin E2 of ATP and noradrenaline co-transmission in the guinea-pig vas deferens.
    Ellis JL; Burnstock G
    J Auton Pharmacol; 1990 Dec; 10(6):363-72. PubMed ID: 1965507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of agents that modulate intracellular cAMP levels on excitatory junction potentials recorded in the guinea-pig vas deferens in vitro.
    Hardy TA; Brock JA
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Dec; 362(6):559-67. PubMed ID: 11138849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the effects of exogenous and endogenous prostaglandins on fast and slow contractions of field-stimulated guinea-pig vas deferens.
    McKay AM; Poyser NL
    Br J Pharmacol; 1995 Nov; 116(6):2679-84. PubMed ID: 8590989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of A1-adenosine receptor antagonists on purinergic transmission in the guinea-pig vas deferens in vitro.
    Hardy TA; Brock JA
    Br J Pharmacol; 1999 Apr; 126(8):1761-8. PubMed ID: 10372818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandin E2 selectively affects purinergic transmission in guinea pig vas deferens.
    Hata F; Kishi I; Saeki K; Takeuchi T; Yagasaki O
    Neuropharmacology; 1991 Oct; 30(10):1107-12. PubMed ID: 1661863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mechanism of action of AMP-induced inhibition of sympathetic neurotransmission in the isolated vas deferens of the rat and guinea-pig.
    Dalziel HH; Sneddon P
    Br J Pharmacol; 1988 Jul; 94(3):961-7. PubMed ID: 2846112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An electrophysiological analysis of the actions of prostaglandin on neuromuscular transmission in the guinea-pig vas deferens.
    Ito Y; Tajima K
    J Physiol; 1979 Dec; 297(0):521-37. PubMed ID: 231652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in the physiological response and ultrastructure of human and guinea pig vas deferens. Effects of prostaglandins, irradiation, and temperature.
    Michailov MC; Murray AB; Zettler F; Grindler-Greimel HW
    Urol Int; 1983; 38(4):234-42. PubMed ID: 6308870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of P2 receptor antagonists and ATPase inhibition on sympathetic purinergic neurotransmission in the guinea-pig isolated vas deferens.
    Sneddon P; Westfall TD; Todorov LD; Todorova SM; Westfall DP; Nickel P; Kennedy C
    Br J Pharmacol; 2000 Mar; 129(6):1089-94. PubMed ID: 10725256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impulse conduction in sympathetic nerve terminals in the guinea-pig vas deferens and the role of the pelvic ganglia.
    Brock JA; Cunnane TC
    Neuroscience; 1992; 47(1):185-96. PubMed ID: 1579207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suramin inhibits excitatory junction potentials in guinea-pig isolated vas deferens.
    Sneddon P
    Br J Pharmacol; 1992 Sep; 107(1):101-3. PubMed ID: 1330153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the factors which determine the time-courses of junction potentials in the guinea-pig vas deferens.
    Cunnane TC; Manchanda R
    Neuroscience; 1990; 37(2):507-16. PubMed ID: 2133355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological evidence that adenosine triphosphate and noradrenaline are co-transmitters in the guinea-pig vas deferens.
    Sneddon P; Westfall DP
    J Physiol; 1984 Feb; 347():561-80. PubMed ID: 6142947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of modulating Ca2+ entry and activating prejunctional receptors on facilitation of excitatory junction potentials in the guinea-pig vas deferens in vitro.
    Hardy TA; Brock JA
    Naunyn Schmiedebergs Arch Pharmacol; 2001 May; 363(5):515-25. PubMed ID: 11383712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of exogenous and endogenous prostaglandins on the fast phase of contraction of the guinea-pig vas deferens produced by electrical field stimulation.
    Christian HC; Poyser NL
    Prostaglandins Leukot Essent Fatty Acids; 1994 Jul; 51(1):57-62. PubMed ID: 7938100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrophysiological analysis of the inactivation of sympathetic transmitter in the guinea-pig vas deferens.
    Cunnane TC; Manchanda R
    J Physiol; 1988 Oct; 404():349-64. PubMed ID: 2908123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.